Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Accenture
McKesson
Mallinckrodt
Federal Trade Commission
Express Scripts
Fuji
AstraZeneca
Cerilliant

Generated: February 17, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for AXIRON

« Back to Dashboard

Payment Methods and Pharmacy Types for AXIRON (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $20,210,348
DRUG STORE $24,705,682
[disabled in preview] $0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 36,499
DRUG STORE 46,708
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
PRIVATE INSURANCE $36,172,578
SELF OR FAMILY $8,743,453
[disabled in preview] $0
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for AXIRON
Drug Units Sold Trends for AXIRON

Annual Sales Revenues and Units Sold for AXIRON

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
AXIRON ➤ Sign Up ➤ Sign Up 2016
AXIRON ➤ Sign Up ➤ Sign Up 2015
AXIRON ➤ Sign Up ➤ Sign Up 2014
AXIRON ➤ Sign Up ➤ Sign Up 2013
AXIRON ➤ Sign Up ➤ Sign Up 2012
AXIRON ➤ Sign Up ➤ Sign Up 2011
AXIRON ➤ Sign Up ➤ Sign Up 2010
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Covington
Express Scripts
McKinsey
AstraZeneca
Cipla
Baxter
Julphar
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.